🚀 VC round data is live in beta, check it out!
Pihlajalinna Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pihlajalinna and similar public comparables like M1 Kliniken, Medica Sur, OncoclĂnicas, Mater Dei and more.
Pihlajalinna Overview
About Pihlajalinna
Pihlajalinna Oyj is a private provider of healthcare and wellbeing services in Finland. The company is engaged in the business of providing healthcare and social care services to municipalities, hospital districts, companies, insurance companies, and private persons. The service selection includes general practitioner and medical specialist services, occupational healthcare, social and healthcare outsourcing, fitness center services, responsible doctor, and remote consultation services as well as residential services and staffing services.
Founded
2014
HQ
Employees
4.4K
Website
Sectors
Financials (LTM)
EV
$656M
Pihlajalinna Financials
Pihlajalinna reported last 12-month revenue of $751M and EBITDA of $128M.
In the same LTM period, Pihlajalinna generated $333M in gross profit, $128M in EBITDA, and $42M in net income.
Revenue (LTM)
Pihlajalinna P&L
In the most recent fiscal year, Pihlajalinna reported revenue of $778M and EBITDA of $132M.
Pihlajalinna expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $751M | XXX | $778M | XXX | XXX | XXX |
| Gross Profit | $333M | XXX | $545M | XXX | XXX | XXX |
| Gross Margin | 44% | XXX | 70% | XXX | XXX | XXX |
| EBITDA | $128M | XXX | $132M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $42M | XXX | $45M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $87M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pihlajalinna Stock Performance
Pihlajalinna has current market cap of $336M, and enterprise value of $656M.
Market Cap Evolution
Pihlajalinna's stock price is $14.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $656M | $336M | 3.7% | XXX | XXX | XXX | $1.98 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPihlajalinna Valuation Multiples
Pihlajalinna trades at 0.9x EV/Revenue multiple, and 5.1x EV/EBITDA.
EV / Revenue (LTM)
Pihlajalinna Financial Valuation Multiples
As of April 19, 2026, Pihlajalinna has market cap of $336M and EV of $656M.
Equity research analysts estimate Pihlajalinna's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pihlajalinna has a P/E ratio of 8.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $336M | XXX | $336M | XXX | XXX | XXX |
| EV (current) | $656M | XXX | $656M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 5.1x | XXX | 5.0x | XXX | XXX | XXX |
| EV/EBIT | 10.2x | XXX | 9.7x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | 1.2x | XXX | XXX | XXX |
| P/E | 8.1x | XXX | 7.6x | XXX | XXX | XXX |
| EV/FCF | 12.5x | XXX | 9.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pihlajalinna Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Pihlajalinna Margins & Growth Rates
Pihlajalinna's revenue in the last 12 month declined by (7%).
Pihlajalinna's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Pihlajalinna's rule of 40 is 7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pihlajalinna's rule of X is (9%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Pihlajalinna Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (7%) | XXX | (11%) | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | (6%) | XXX | (11%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 7% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (9%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 64% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pihlajalinna Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pihlajalinna | XXX | XXX | XXX | XXX | XXX | XXX |
| M1 Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Medica Sur | XXX | XXX | XXX | XXX | XXX | XXX |
| OncoclĂnicas | XXX | XXX | XXX | XXX | XXX | XXX |
| Mater Dei | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pihlajalinna M&A Activity
Pihlajalinna acquired XXX companies to date.
Last acquisition by Pihlajalinna was on XXXXXXXX, XXXXX. Pihlajalinna acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pihlajalinna
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPihlajalinna Investment Activity
Pihlajalinna invested in XXX companies to date.
Pihlajalinna made its latest investment on XXXXXXXX, XXXXX. Pihlajalinna invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pihlajalinna
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pihlajalinna
| When was Pihlajalinna founded? | Pihlajalinna was founded in 2014. |
| Where is Pihlajalinna headquartered? | Pihlajalinna is headquartered in Finland. |
| How many employees does Pihlajalinna have? | As of today, Pihlajalinna has over 4K employees. |
| Who is the CEO of Pihlajalinna? | Pihlajalinna's CEO is Tuomas Hyyrylainen. |
| Is Pihlajalinna publicly listed? | Yes, Pihlajalinna is a public company listed on Nasdaq Helsinki. |
| What is the stock symbol of Pihlajalinna? | Pihlajalinna trades under PIHLIS ticker. |
| When did Pihlajalinna go public? | Pihlajalinna went public in 2015. |
| Who are competitors of Pihlajalinna? | Pihlajalinna main competitors are M1 Kliniken, Medica Sur, OncoclĂnicas, Mater Dei. |
| What is the current market cap of Pihlajalinna? | Pihlajalinna's current market cap is $336M. |
| What is the current revenue of Pihlajalinna? | Pihlajalinna's last 12 months revenue is $751M. |
| What is the current revenue growth of Pihlajalinna? | Pihlajalinna revenue growth (NTM/LTM) is (7%). |
| What is the current EV/Revenue multiple of Pihlajalinna? | Current revenue multiple of Pihlajalinna is 0.9x. |
| Is Pihlajalinna profitable? | Yes, Pihlajalinna is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pihlajalinna? | Pihlajalinna's last 12 months EBITDA is $128M. |
| What is Pihlajalinna's EBITDA margin? | Pihlajalinna's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Pihlajalinna? | Current EBITDA multiple of Pihlajalinna is 5.1x. |
| What is the current FCF of Pihlajalinna? | Pihlajalinna's last 12 months FCF is $52M. |
| What is Pihlajalinna's FCF margin? | Pihlajalinna's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Pihlajalinna? | Current FCF multiple of Pihlajalinna is 12.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.